Estimaciones de analistas de Wall Street para SI-BONE, Inc. (SIBN): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 10 |
| Mantener | 0 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 10 |
| Calificación media (1-5) | 1.00 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-09 | $-0.13 | ||
| 2026-08-03 | $-0.09 | $-0.15 | +39.8% |
| 2026-05-11 | $-0.10 | $-0.17 | +41.2% |
| 2026-02-23 | $-0.04 | $-0.13 | +69.2% |
| 2025-11-10 | $-0.11 | $-0.16 | +31.2% |
| 2025-08-04 | $-0.14 | $-0.19 | +26.3% |
| 2025-05-05 | $-0.15 | $-0.24 | +37.5% |
| 2025-02-24 | $-0.11 | $-0.15 | +24.4% |
Ratios de valoración
| Precio / Valor contable | 4.50 |
| EV / EBITDA | -158.17 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $42.1M | $48.0M | $55.4M | $67.3M | $73.4M | $90.2M | $106.4M | $138.9M | $167.2M | $200.9M |
| Coste de Ventas | $5.2M | $5.1M | $4.8M | $6.8M | $8.9M | $10.4M | $15.7M | $29.5M | $35.1M | $41.0M |
| Beneficio Bruto | $36.9M | $42.9M | $50.5M | $60.5M | $64.5M | $79.7M | $90.7M | $109.4M | $132.1M | $159.9M |
| I+D | $6.4M | $5.5M | $5.4M | $7.3M | $9.5M | $12.4M | $13.6M | $15.0M | $16.6M | $17.4M |
| Generales y Administrativos | $48.1M | $54.7M | $57.1M | $89.2M | $93.6M | $119.0M | $136.7M | $141.3M | $150.8M | $164.8M |
| Gastos Operativos | $54.5M | $60.2M | $62.5M | $96.5M | $103.1M | $131.4M | $150.3M | $156.4M | $167.4M | $182.2M |
| Beneficio Operativo | -$17.6M | -$17.4M | -$12.0M | -$36.0M | -$38.6M | -$51.7M | -$59.6M | -$46.9M | -$35.2M | -$22.3M |
| EBITDA | -$16.2M | -$15.8M | -$11.6M | -$32.7M | -$36.5M | -$51.0M | -$55.0M | -$34.4M | -$23.1M | -$10.9M |
| Gastos por Intereses | $3.3M | $6.2M | $5.1M | $4.9M | $6.1M | $5.4M | $2.8M | $3.5M | $3.4M | $5.3M |
| Beneficio Antes de Impuestos | -$20.6M | -$23.0M | -$17.5M | -$38.4M | -$43.7M | -$56.6M | -$61.3M | -$43.3M | -$30.9M | -$18.9M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$20.6M | -$23.0M | -$17.5M | -$38.4M | -$43.7M | -$56.6M | -$61.3M | -$43.3M | -$30.9M | -$18.9M |
| BPA | $-1.33 | $-1.66 | $-1.10 | $-1.72 | $-1.50 | $-1.71 | $-1.79 | $-1.13 | $-0.75 | $-0.44 |
| BPA Diluido | $-1.33 | $-1.66 | $-1.10 | $-1.72 | $-1.50 | $-1.71 | $-1.79 | $-1.13 | $-0.75 | $-0.44 |
| Acciones en Circulación (Diluidas) | $15.5M | $13.9M | $15.9M | $24.7M | $29.1M | $33.1M | $34.2M | $38.4M | $41.5M | $43.5M |
Precio
| Precio | $18.54 |
| Capitalización | $822M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: AIRS · AQST · AVNS · AVXL · BFLY · CLPT · INNV
Explorar sector: Healthcare · Medical - Devices
Más secciones de SIBN: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones